Incretin combination therapy for the treatment of non-alcoholic steatohepatitis
Diabetes, Obesity and Metabolism 22(8):1328-1338, 2020
Glucagon resistance at the level of amino acid turnover in obese subjects with hepatic steatosis
Diabetes 69(6):1090-1099, 2020
Multi-omics characterization of a diet-induced obese model of non-alcoholic steatohepatitis
Scientific Reports 10(1):1148, 2020
Validity of biopsy-based drug effects in a diet-induced obese mouse model of biopsy-confirmed NASH
BMC Gastroenterology 19(1):228, 2019
Mastiha (Pistacia Lentiscus) improves gut microbiota diversity, hepatic steatosis and disease activity in a biopsy-confirmed mouse model of advanced non-alcoholic steatohepatitis and fibrosis
Molecular Nutrition & Food Research 63(24):e1900927, 2019
Towards a standard diet-induced and biopsy-confirmed mouse model of non-alcoholic steatohepatitis: Impact of dietary fat source
World Journal of Gastroenterology 25(33):4904-4920, 2019
Non-alcoholic fatty liver disease alters expression of genes governing hepatic nitrogen conversion
Liver International 39(11):2094-2101, 2019
Hepatic molecular characteristics of patients with varying degrees of nonalcoholic steatohepatitis compared to healthy normal weight individuals
American Journal of Physiology - Gastroenterology and Liver Physiology 316(4):G462-G472, 2019